Formulation and delivery continues to hold strong as the month of January draws to a close. Despite our previous doubts over the viability of RNA-based therapeutics due to difficulties associated with...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)